ERBB2 and breast cancer: Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression, accounting for 15% to 20% of all BC cases (Foulkes, Smith & Reis-Filho, 2010; Perou, 2011).